May 2, 2024 / Rymedi and Precision Genetics, two leading pioneers in healthcare technology solutions, proudly announce their strategic partnership aimed at transforming health outcomes and efficiencies through precision medicine. The collaboration will combine Precision Genetics’ PrecisionOp, a personalized means to reduce adverse drug reactions and reliance on post-operative opioids for patients undergoing surgery, and Rymedi’s block-chain enabled clinical trial and registry platform.
